Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-01-30 · accession 0001628280-26-005154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | 2026-01-30 | PCRX | Teehan Brendan | Chief Commercial Off | F - Tax | $20.54 | -5,182 | 49.2K | -10% | -$106.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-30 | F | D | 5,182 | $20.54 | 49,220.27 | D | — | — | (F1) Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. |